James D. Ralston

Pandemic uropathogenic fluoroquinolone-resistant Escherichia coli have enhanced ability to persist in the gut and cause bacteriuria in healthy women.

E. Sokurenko, D. Scholes, V. Tchesnokova, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study

Joseph T. Glessner, J. Glessner, H. Hakonarson, 2021, medRxiv.

Increase in the Rate of Gut Carriage of Fluoroquinolone-Resistant Escherichia coli despite a Reduction in Antibiotic Prescriptions

E. Sokurenko, S. Weissman, V. Tchesnokova, 2022, medRxiv.

Accounting for Social Risk Does not Eliminate Race/Ethnic Disparities in COVID-19 Infection Among Insured Adults: a Cohort Study

R. Grant, J. Ellis, E. Bayliss, 2022, Journal of General Internal Medicine.

Rapid and Extensive Expansion in the United States of a New Multidrug-resistant Escherichia coli Clonal Group, Sequence Type 1193

Rosemary C. She, F. Fang, E. Sokurenko, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants

E. Sokurenko, M. Samadpour, K. Deng, 2021, bioRxiv.

Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants

E. Sokurenko, H. Kulasekara, M. Samadpour, 2021, Journal of clinical microbiology.

Acquisition of the L 452 R mutation in the ACE 2-binding interface of Spike protein 1 triggers recent massive expansion of SARS-Cov-2 variants 2

E. Sokurenko, M. Samadpour, K. Deng, 2021 .

Increase in the community circulation of ciprofloxacin-resistant Escherichia coli despite reduction in antibiotic prescriptions

E. Sokurenko, S. Weissman, L. Larson, 2023, Communications medicine.